Navigation Links
Electronic tracking system can improve follow-up after an abnormal Pap test
Date:8/20/2010

(Boston) Researchers from Boston University School of Medicine (BUSM) report that physicians who use an automated, electronic medical record (EMR) tracking system to follow-up on patients with an abnormal Pap test could increase the number of women who achieved diagnostic resolution and have women achieve resolution in less time than using traditional methods. These findings appear in the Journal of General Internal Medicine.

Screening for cervical cancer with a Pap test is only as successful as the follow-up rate for an abnormal result. If a patient has a Pap test, yet does not receive appropriate follow-up for an abnormal result, then the opportunity to prevent or treat pre-cancerous lesions or cervical cancer is missed and the Pap test is ineffective.

The advent of tracking systems provides great potential to address inadequate follow-up on a systemic level. "We developed a tracking system for our internal EMR, and evaluated this tracking system as an intervention to improve adequate follow-up of abnormal Pap tests," said lead author Elizabeth Dupuis, MD, from the Section of General Internal Medicine in the Department of Medicine, and the Women's Health Interdisciplinary Research Center at BUSM.

The BUSM researchers compared abnormal Pap test follow-up rates for the 24 months prior to implementing the tracking system with rates 12 months after its implementation. The evaluation monitored all subjects for 12 months from the date of their abnormal Pap test through diagnostic resolution. Controlling for type of abnormality and practice location, the adjusted time to resolution decreased significantly from 108 days prior to implementing the tracking system to 86 days after implementation.

"Although our study could not demonstrate that with this system we directly avoided cases of invasive cervical cancer, we did show that in an at-risk urban population, an automated, EMR-based tracking system reduced the time to resolution, and increased the number of women who achieved diagnostic resolution," added Dupuis. "Most EMRs in use today do not have such tracking systems developed. Our data suggests that such systems can improve patient safety and patient care."

The researchers believe a combination of both systems and patient barriers impede adequate abnormal Pap test follow-up. Patient barriers include difficulty in keeping follow-up appointments, limited understanding of the significance of the abnormality and other life-issues taking priority. Systems barriers include failure of the provider to be aware of an abnormal result, and limited capability to systematically track patients who do not keep follow-up appointments. "Our program addressed the systems barriers by giving providers tools to allow them to more easily track subjects after an abnormal Pap test. Our higher baseline follow-up rates may already reflect some of the benefits of an EMR system; however, delays persisted without a tracking system," said Dupuis.


'/>"/>

Contact: Jenny Eriksen
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Related biology news :

1. Electronic cigarettes require more suction than conventional brands
2. First step toward electronic DNA sequencing: Translocation through graphene nanopores
3. Multicard to Supply Secure IT Kits Under German Federal Governments Electronic ID Program
4. SCM Microsystems to Supply Readers for German Electronic ID Program
5. Project focuses on physical stresses caused by multi-touch electronic devices
6. ScriptRx and DigitalPersona Team Up to Secure Emergency Room and Urgent Care Electronic Medical Records
7. Plastic electronics could slash the cost of solar panels
8. Electronic medical records may accelerate genome-driven diagnoses and treatments
9. Hugging the heart electronically
10. Flexible electronics could help put off-beat hearts back on rhythm
11. Top-Three US Bank Chooses CIC Electronic Signature Technology for Branch-Wide Deployment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: